Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study.

J Parkinsons Dis · 2021 · PMC7990424 · PMID 33164945

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

UPDRS assessments (UPDRS Part II and III) showed nominally significant improvement from baseline, particularly with 24-hour ND0612 infusion ( Table 2 ).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.